CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Owensboro Medical Health System

Owensboro Medical Health System provides healthcare services to a ten-county area in Southern Indiana and Western Kentucky with a mission of healing the sick and improving the health of the community.

prolacta bioscience

prolacta bioscience is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Monrovia, CA. To find more information about prolacta bioscience, please visit www.prolacta.com

DataMetrix

DataMetrix is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Salt Lake City, UT. To find more information about DataMetrix, please visit www.data-metrix.com

Surveillance Data

Surveillance Data is a Morrisville, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

NavigatorMD

NavigatorMD, Inc. was founded in 2005 to address the rising demand for an integrated data analysis and health plan management solution. As an insurance broker, Ernest Youngblood, founder of NavigatorMD, watched the progressive increase in health care costs and identified the opportunity for organizations to save money while improving the overall wellness of a plan population. Youngblood led the organization of a multi-disciplinary team of healthcare professionals, ranging from physicians and pharmacologists to benefit consultants and C-Suite executives to develop its first product, Design180®. The intended purpose of this advisory team was to establish an understanding of the problems and hurdles that faced the business community in managing and understanding their health claims spend. This unique insight and knowledge was the basis of its technically sound, business-oriented approach to claims analysis and comprehensive health plan management. NavigatorMD launched its first product in 2008 with the mission of lowering health care costs and adding value to health plans by focusing on manageable costs and utilizing the power of data. Influenced by the concept of value-based insurance design, our health claims data analytics software was created under the advisory of various professionals, including former VP of Strategic H.R. Initiatives at Pitney Bowes, David Hom, who served as an early member of the NavigatorMD's Board of Directors. Early success and escalating interest in the product resulted in the formation of an advisory board comprising several influential experts in the field of Value-Based Insurance Design (VBID). In addition, NavigatorMD received support and referrals from two of the largest pharmaceutical companies in the U.S. that were responsible for funding the development of the Center for Value Based Health Management, among other value-based health care initiatives. NavigatorMD, the first step toward proactive health plan management.